FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

715773006: Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3710421016 Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3710422011 Insulin aspart- and insulin degludec-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5476421000241115 produit contenant de l'insuline asparte et de l'insuline dégludec sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) Is a Product containing insulin aspart and insulin degludec (medicinal product) true Inferred relationship Some
Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) Is a Product containing insulin degludec in parenteral dose form (medicinal product form) true Inferred relationship Some
Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Insulin aspart true Inferred relationship Some 1
Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Insulin degludec (substance) true Inferred relationship Some 2
Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Some
Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) Is a Product containing insulin aspart in parenteral dose form (medicinal product form) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Insulin aspart and insulin degludec only product in parenteral dose form Is a True Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) Inferred relationship Some

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start